Remepy
PrivateLast Round
Series A
Aug 12, 2026
Total Funding Raised
$51M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Remepy is a biotechnology company that develops hybrid drugs, which combine traditional medications with digital therapeutic software to enhance treatment effectiveness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remepy Comparables
Compare Remepy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amalgam Rx | 78% | |
| Click Therapeutics | 78% | |
| Newel Health | 74% | |
Remepy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 12, 2026 | ||||
| Seed | May 1, 2024 |
Key People
Founding team and executive leadership
Remepy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vine Ventures | Series A, Seed |
| NFX | Series A, Seed |
| Fresh.Fund | Pre Seed, Series A, Seed |
| Firstime | Seed |
| IT-Farm Corporation | Series A |
| StageNext Fund | Pre Seed, Seed |
| Qumra Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2026
$36M round led by M Ventures and O.G. Venture Partners.
- Jul 24, 2026
Monthly visitors increased 155% MoM, reaching 3.9K.
Remepy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remepy's valuation, stock price, and market status.